Skip to main content
Diane Hershock, MD, Oncology, Hershey, PA

DianeMHershockMDPhD

Oncology Hershey, PA

Gastrointestinal Cancer, Head & Neck Cancer, Hematologic Oncology, Melanoma

Senior Medical Director, Oncology Clinical Development

Dr. Hershock is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Hershock's full profile

Already have an account?

  • Office

    500 University Dr
    Hershey, PA 17033
    Phone+1 717-531-0003
    Fax+1 717-531-4969

Summary

  • Dr. Diane Hershock is an oncologist now at Jefferson Northeast; previously affiliated with Penn State Milton S. Hershey Medical Center as well as Abramson Cancer Center at Penn. She received her medical degree from Sidney Kimmel Medical College and has been in practice 24 years. She specializes in head and neck oncology, melanoma and cutaneous malignancies, and gastrointestinal oncology. She has also been heavily involved in early drug development in industry and has been on several FDA submission teams.

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 1996 - 1999
  • Temple University Hospital
    Temple University HospitalResidency, Internal Medicine, 1993 - 1996
  • Sidney Kimmel Medical College at Thomas Jefferson University
    Sidney Kimmel Medical College at Thomas Jefferson UniversityClass of 1993
  • Thomas Jefferson University
    Thomas Jefferson UniversityPh.D., Pharmacology, 1985 - 1989
  • Saint Joseph's University
    Saint Joseph's UniversityB.S., Biology, 1977 - 1981

Certifications & Licensure

  • NJ State Medical License
    NJ State Medical License 2024 - 2025
  • PA State Medical License
    PA State Medical License 1994 - 2024
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • University Teaching Assistantship Thomas Jefferson University, 1988
  • National Research Service Award Cell Biology and Pathology, Thomas Jefferson University, 1987
  • University Teaching Assistantship Thomas Jefferson University, College of Allied Health, Immunohematology, 1986
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Radiotherapy with or without erythropoietin for anemic patients with head and neck cancer: a randomized trial of the Radiation Therapy Oncology Group (RTOG 99-03)  
    Machtay, M, Pajak, TF, Suntharalingam, M, Shenouda G, Hershock D, Stripp D, Cmelak AJ, Schulsinger, A, Fu KK, Int J Radiation Oncology, Biology, Physics, 1/1/2007
  • Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer  
    Posner, MR, Hershock D, Blajman CR et al, NEJM, 1/1/2007
  • Percutaneous placement of an implantable arm port through an internal mammary venous pathway: case report  
    Urbania T, Hershock D, Clark TWI, J. Vascular Access, 1/1/2003
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Abstracts/Posters

  • Confirmation of the reliability and validity of Lung Cancer Symptom Scale (LCSS) forpPatients with malignant pleural mesothelioma: comparison of chemotherapy-pretreate...
    Arduino JM, Kindler HL, Hollen PJ, Sun X, Baas P, Bucci ME, Lubiniecki GM, Hershock DM, Krug LM, World Lung Conference, San Francisco, 7/1/2009
  • A Phase III trial of docetaxel, cisplatin and 5-fluorouracil (TPF) versus cisplatin and 5-fluorouracil (PF) induction chemotherapy (IC) followed by chemoradiotherapy (...
    Posner, MR, Hershock D, Le-Lann L, Devlin, PM, Haddad RI, ASCO, 1/1/2006
  • A phase I combination trial of fixed-dose rate gemcitabine and irinotecan in patients with advanced pancreatic and biliary cancer.
    Sun W, Theobald M, Hershock D, Haller DG, ASCO, 1/1/2004
  • Join now to see all

Lectures

  • "CTEP/NCI-cMet Program-Preclinical/Clinical Data to the Drug Development Group for Approval to Develop" 
    Bethesda, MD - 12/1/2008
  • "Chemical Carcinogenesis/Clinical Implications in Oncology" 
    Graduate School, Thomas Jefferson University Hospital - 7/1/2008
  • Grand Rounds: "Update on Head/Neck Cancers in the Community" 
    Grandview Hospital - 12/1/2007
  • Join now to see all

Professional Memberships